Tag Archives: VNDA

Top Casino Stocks To Watch Right Now

Federal investigators have halted an alleged student loan debt relief scam that bilked more than $11 million from consumers nationwide.

Strategic Student Solutions and several related companies falsely promised to reduce or eliminate student loan debt and also offered the borrowers non-existent credit repair services, in exchange for upfront fees and monthly payments, the Federal Trade Commission charged incourt papersmade public Thursday.

Although borrowers allegedly got no relief from their debts, Dave Green, owner of the companies, used corporate funds to pay for jewelry, casino tabs, mortgage payments, luxury vehicles and construction of a pool, the FTC charged.

.oembed-asset-link { border-bottom: 1px solid #e1e1e1; } .oembed-link-anchor { display: block; clear: both; } p.oembed-link-desc { font-size: 100%; color: #666; font-weight: normal; margin: 0 14px 14px 14px; font-family: ‘Futura Today Light’; text-align: left; line-height: 120%; }

FTC Complaint v Strategic Student Solutions

Top Casino Stocks To Watch Right Now: ClubCorp Holdings, Inc.(MYCC)

Advisors’ Opinion:

  • [By Steve Symington]

    Shares of ClubCorp Holdings Inc. (NYSE:MYCC) jumped 15.7% Thursday after reports stating the private golf and country-club specialist is considering strategic alternatives.

Top Casino Stocks To Watch Right Now: Vanda Pharmaceuticals Inc.(VNDA)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another biotechnology player that looks poised to trigger a big breakout trade is Vanda Pharmaceuticals (VNDA), which is focused on the development and commercialization of clinical-stage drug candidates for central nervous system disorders. This stock has been on fire so far in 2013, with shares up a whopping 258%.

    If you take a look at the chart for Vanda Pharmaceuticals, you’ll notice that this stock has recently broke out above some near-term overhead resistance levels at $12.34 to $12.66 a share with solid upside volume. So far, this breakout has held and now shares of VNDA are quickly moving within range of triggering an even bigger breakout trade.

    Traders should now look for long-biased trades in VNDA if it manages to break out above its 52-week high at $13.30 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action 908,467 shares. If that breakout hits soon, then VNDA will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $17 a share.

    Traders can look to buy VNDA off any weakness to anticipate that breakout and simply use a stop that sits right below some near-term support at $12 a share. One could also buy VNDA off strength once it takes out $13.30 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top Casino Stocks To Watch Right Now: iShares Intermediate Credit Bond (CIU)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of ARKANSAS FINANCIAL GROUP, INC.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=ARKANSAS+FINANCIAL+GROUP%2C+INC.

    These are the top 5 holdings of ARKANSAS FINANCIAL GROUP, INC.SPDR Dow Jones Industrial Average (DIA) – 257,721 shares, 25.79% of the total portfolio. Shares added by 0.48%iShares Core S&P Mid-Cap (IJH) – 269,365 shares, 22.36% of the total portfolio. Shares added by 0.51%iShares 1-3 Year Credit Bond (CSJ) – 375,399 shares, 19.16% of the total portfolio. Shares added by 8.03%iShares Intermediate Credit Bond (CIU) – 258,147 shares, 13.64% of the total portfolio. Shares added by 1.50%Vanguard Mid-Cap ETF – DNQ (VO)

Top Growth Stocks For 2018

Sarasota, FL, based Investment company Cumberland Advisors Inc buys Guggenheim S&P 500 Equal Weight, iShares Transportation Average, SPDR Select Sector Fund – Industrial, Materials Select Sector SPDR, iShares MSCI Chile Capped Investable Market Index , SPDR S&P Regional Banking, SPDR S&P Insurance, Guggenheim S&P 500 Top 50, iShares Edge MSCI Min Vol Emerging Markets, sells PowerShares QQQ Trust Series 1, iShares North American Tech-Multimedia Networking, ALPS Sector Dividend Dogs, Vanguard Small-Cap Growth, iShares Core S&P Small-Cap during the 3-months ended 2017-09-30, according to the most recent filings of the investment company, Cumberland Advisors Inc. As of 2017-09-30, Cumberland Advisors Inc owns 40 stocks with a total value of $153 million. These are the details of the buys and sells.

New Purchases: IYT, XLI, ECH, EEMV, Added Positions: RSP, XLB, KRE, KIE, XLG, Reduced Positions: QQQ, IGN, VBK, XLK, DVY, KBWB, SCZ, IHI, AAXJ, IBB, Sold Out: SDOG, IJR, UPRO, EPD, ETP,

For the details of CUMBERLAND ADVISORS INC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=CUMBERLAND+ADVISORS+INC

Top Growth Stocks For 2018: Vanda Pharmaceuticals Inc.(VNDA)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another biotechnology player that looks poised to trigger a big breakout trade is Vanda Pharmaceuticals (VNDA), which is focused on the development and commercialization of clinical-stage drug candidates for central nervous system disorders. This stock has been on fire so far in 2013, with shares up a whopping 258%.

    If you take a look at the chart for Vanda Pharmaceuticals, you’ll notice that this stock has recently broke out above some near-term overhead resistance levels at $12.34 to $12.66 a share with solid upside volume. So far, this breakout has held and now shares of VNDA are quickly moving within range of triggering an even bigger breakout trade.

    Traders should now look for long-biased trades in VNDA if it manages to break out above its 52-week high at $13.30 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action 908,467 shares. If that breakout hits soon, then VNDA will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $17 a share.

    Traders can look to buy VNDA off any weakness to anticipate that breakout and simply use a stop that sits right below some near-term support at $12 a share. One could also buy VNDA off strength once it takes out $13.30 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top Growth Stocks For 2018: Allot Communications Ltd.(ALLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Telecommunications services shares gained around 0.98 percent in trading on Thursday. Meanwhile, top gainers in the sector included Telefonica S.A. (ADR) (NYSE: TEF), and Allot Communications Ltd (NASDAQ: ALLT).

Top Growth Stocks For 2018: Kering S.A. (PPRUF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Kering Group (OTC:PPRUF), which operates the Gucci and YSL brands, said on February 10 that 2016 saw a same-store sales increase of 11 percent in Asia ex-Japan, which was mostly led by a rebound in China. LVMH, which owns brands such as Louis Vuitton, Bulgari, and Hennessy, also highlighted positive momentum going forward in its fourth-quarter earnings call with investors. Hugo Boss Group’s mainland China same-store sales also increased close to 20 percent during 2016, adjusted for currency.

Best Heal Care Stocks For 2018

Did the labor market rebound after adding just 98,000 jobs in March?

Thats the question this weeks economic news will answer. Most analystsbelieve job growth resumed its solid pace, but another disappointing showing would raise concerns about the economys health after the anemic first-quarter growth reported by the government on Friday.

Meanwhile, the Federal Reserve isnt expected to raise interest rates at a meeting that concludes Wednesday, but could give clues about a June hike. The week also features data on consumer spending, manufacturing and service-sector activity.

Consumer spending was sluggish in January and February, largely because unusually warm weather crimped demand for utilities. But March was snowier and colder in the Midwest and Northeast, and Nomura economist Lewis Alexander expects a sharp recovery in heating usage. At the same time, a core measure of retail sales picked up smartly as consumers received delayed tax refunds but auto sales continued to drop. Overall, economists expect the Commerce Department to report Monday that consumer spending rose a modest 0.2% in March.

Best Heal Care Stocks For 2018: Chesapeake Energy Corporation(CHK)

Advisors’ Opinion:

  • [By Chris Lange]

    And Chesapeake Energy Corp. (NYSE: CHK) is expected to report its most recent quarterly results on Thursday. The consensus estimates call for $0.15 in EPS and $2.3 billion in revenue. Shares closed trading at $5.06 on Friday, in a 52-week range of $4.38 to $8.20. The consensus price target is $5.36.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was Chesapeake Energy Corp. (NYSE: CHK) which traded down 3.2% at $6.12. The stocks 52-week range is $3.54 to $8.20. Volume was roughly 76.8 million versus the daily average of 38.3 million shares.

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Treehouse Foods (THS) , TG Therapeutics (TGTX) , Kinder Morgan (KMI) , Magellan Midstream Partners (MMP) , Chesapeake Energy (CHK) and Arconic (ARNC) .

Best Heal Care Stocks For 2018: Vanda Pharmaceuticals Inc.(VNDA)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another biotechnology player that looks poised to trigger a big breakout trade is Vanda Pharmaceuticals (VNDA), which is focused on the development and commercialization of clinical-stage drug candidates for central nervous system disorders. This stock has been on fire so far in 2013, with shares up a whopping 258%.

    If you take a look at the chart for Vanda Pharmaceuticals, you’ll notice that this stock has recently broke out above some near-term overhead resistance levels at $12.34 to $12.66 a share with solid upside volume. So far, this breakout has held and now shares of VNDA are quickly moving within range of triggering an even bigger breakout trade.

    Traders should now look for long-biased trades in VNDA if it manages to break out above its 52-week high at $13.30 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action 908,467 shares. If that breakout hits soon, then VNDA will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $17 a share.

    Traders can look to buy VNDA off any weakness to anticipate that breakout and simply use a stop that sits right below some near-term support at $12 a share. One could also buy VNDA off strength once it takes out $13.30 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Best Heal Care Stocks For 2018: Neometals Ltd (RRSSF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

candlestick chart

5 Tax Bill Conference Report Sections for Agents to Watch

9 Details That Could Be Signs of Life Insurance Fraud

Americo Introduces a Single-Premium Immediate LTCI Policy

A long-running lawsuit between the Trump administration, House Republicans and Democratic attorneys general over billions of dollars of Affordable Care Act public exchange plan subsidies has been settled, according to an agreement filed in federal court Friday.

The settlement agreement, details of which weren’t available in the filings but described as “conditional,” could pave the way for eventual payment of the cost-sharing reduction payments, or CSRs. The CSRs had been paid to health insurers as a way to subsidize some lower-income patients’ insurance co-payments and deductibles, allowing them easier access to health care.

(Related: ACA Mandate Clobbers ACA Subsidy: CBO)

The Trump administration had stopped making the payments, throwing the Affordable Care Act’s markets into chaos and causing premiums to rise, and state Democratic attorneys general continued the legal effort to try and preserve the subsidies.

candlestick chart: Investment Technology Group, Inc.(ITG)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Investment Technology Group Inc. (NYSE: ITG) was downgraded to Market Perform from outperform by KeefeBruyette & Woods.

    Liquidity Services Inc. (NASDAQ: LQDT) was raised to Buy from Underperform, and the price target was raised up to $45 from $28.50, at Merrill Lynch.

candlestick chart: Nu Skin Enterprises Inc.(NUS)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Citigroup’s Beth Kite calls Nu Skin Enterprises’ (NUS) earnings and guidance “awfully disappointing.” She explains why:

    “Frustrating” Describes 4Q15 & 2016 Guidance:Nu Skin (i) reported 4Q15 EPS of $0.62, 11 cents below consensus and us, and (ii) lowered 2016 EPS guidance, from $3.25-$3.40 to $2.40-$2.60.Nu Skin had three LTO’s in 4Q152 succeeded and 1 failed. The failure had far less to do with the product than with the sales strategy…

    Is Guidance Too Conservative or Is It Really This Bad? We get that Me failed to sell well in South Korea with the 12-month cartridge commitment. But given the strength in reps globally, the strength of Youth from its two LTOs in 2H15, and good results from Me when sold in Japan without the 12-month commitment, we wonder if guidance is aggressive to the downside. Indeed, the word “conservative” was said a lot by mgmt on the brief earnings call when describing guidance revisions.

    Maintaining Buy: While we now have less confidence in mgmt, from an external perspective, to forecast its results accurately, and from an internal perspective, to course correct quicklyi.e., why didn’t they drop the 12-month plan for Me in South Korea when it so obviously wasn’t workingwe are still confident in Youth & Me. The rep growth in South Asia/Pacific from Youth in 3Q led to better 4Q sales than we’d expected, Youth’s Americas LTO in 4Q drove lc sales up 26% YoY, and Me not only sold through in Japan in 4Q but also drove reps higher. We imagine that investors may have little patience or confidence in Nu Skin for a while, understandably. But the bar seems set fairly low now, so we are cautiously optimistic that Nu Skin can dig itself out of this hole as we go through 2016 and Me & Youth roll out more fully.

    Shares of Nu Skin have tumbled 13% to $27.31 at 2:11 p.m. today.

  • [By Roberto Pedone]

    Nu Skin Enterprises (NUS) is a direct selling company, which develops and distributes personal care products and nutritional supplements that are sold under the Nu Skin and Pharmanex brands. This stock closed up 5.4% at $92.96 in Monday’s trading session.

    Monday’s Volume: 2 million

    Three-Month Average Volume: 900,802

    Volume % Change: 85%

    From a technical perspective, NUS ripped higher here right above some near-term support at $85 with heavy upside volume. This move pushed shares of NUS into breakout and new 52-week-high territory, since the stock took out some near-term overhead resistance levels at $88.20 to $89.69. This move also pushed shares of NUS above the upper-end of its recent range that saw the stock trend between $82 to just above $89.

    Traders should now look for long-biased trades in NUS as long as it’s trending above support at $85 and then once it sustains a move or close above Monday’s high of $93.33 with volume that this near or above 900,802 shares. If we get that move soon, then NUS will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $100 to $105.

  • [By Scott Rubin]

    Stock gainers included Mercadolibre Inc (NASDAQ: MELI), up almost 14 percent, and Nu Skin Enterprises, Inc. (NYSE: NUS), which added 12 percent. The positive gains in both stocks were due to strong earnings reports. Shares of Liberty Interactive Group (NASDAQ: QVCA) plunged almost 22 percent on Friday due to disappointing sales growth in its fiscal second quarter. Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) lost 16 percent after a disappointing study involving its Opdivo drug.

  • [By Craig Jones]

    Nu Skin Enterprises, Inc. (NYSE: NUS) is trading sharply higher on Friday, but options traders are buying puts in the name, said Jon Najarian. Traders were buying the June 50 puts and they paid around 6 percent for them, so they don't see much upside in Nu Skin Enterprises, explained Najarian. He followed the trade and he is planning to hold the position for a month.

candlestick chart: Vanguard Extended Duration Treasury ETF (EDV)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    The 11 ETF fee cuts unveiled by Vanguard include a significant portion of the issuer's fixed income lineup. All of the following saw annual fees reduced to 0.07 percent from 0.1 percent:

    Vanguard Extended Duration Treasury ETF (NYSE: EDV). Vanguard Intermediate-Term Bond ETF (NYSE: BIV). Vanguard Intmdte Tm Govt Bd ETF (NASDAQ: VGIT). Vanguard Long Term Corporate Bond ETF (NASDAQ: VCLT). Vanguard Lg Term Govt Bd ETF (NASDAQ: VGLT). Vanguard Mortgage Bkd Sects ETF (NASDAQ: VMBS).

    and the Vanguard Short Term Corporate Bond ETF (NASDAQ: VCSH).

candlestick chart: VALE S.A.(VALE)

Advisors’ Opinion:

  • [By Craig Jones]

    On CNBC's Fast Money Halftime Report, Jon Najarian spoke about unusually high put options activity in Arconic Inc (NYSE: ARNC) and Vale SA (ADR) (NYSE: VALE).

  • [By Ben Levisohn]

    Mosaic (MOS) tumbled to the bottom of the S&P 500 today after announcing that it would buy Vale’s (VALE) fertilizer unit.

    Getty Images

    Mosaicdropped 1.1% to $27.77 today, while the S&P 500 advanced 0.2% to 2,262.53.

candlestick chart: Intercontinental Exchange Inc.(ICE)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Altria (MO) , Intercontinental Exchange (ICE) and Micron Technology (MU) .

    Cramer was bearish on NVIDIA (NVDA) and Reynolds American (RAI) .

candlestick chart: Vanda Pharmaceuticals Inc.(VNDA)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another biotechnology player that looks poised to trigger a big breakout trade is Vanda Pharmaceuticals (VNDA), which is focused on the development and commercialization of clinical-stage drug candidates for central nervous system disorders. This stock has been on fire so far in 2013, with shares up a whopping 258%.

    If you take a look at the chart for Vanda Pharmaceuticals, you’ll notice that this stock has recently broke out above some near-term overhead resistance levels at $12.34 to $12.66 a share with solid upside volume. So far, this breakout has held and now shares of VNDA are quickly moving within range of triggering an even bigger breakout trade.

    Traders should now look for long-biased trades in VNDA if it manages to break out above its 52-week high at $13.30 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action 908,467 shares. If that breakout hits soon, then VNDA will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $17 a share.

    Traders can look to buy VNDA off any weakness to anticipate that breakout and simply use a stop that sits right below some near-term support at $12 a share. One could also buy VNDA off strength once it takes out $13.30 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

stock picks

What’s happening?

Shares of Goldman Sachs Group Inc. (NYSE:GS) plunged 5% in active trading on Tuesday after its earnings failed to meet Wall Street’s expectations.

So what

Goldman reported earnings of $5.15 per share, below the consensus forecast of $5.31 per share. A noteworthy decline in Fixed Income, Currency, and Commodities (FICC) income stunned analysts, as the company reported earning just $1.69 billion from trading activities, down from $2 billion in the prior quarter. Trading revenue grew just 1% year over year.

Image source: Getty Images.

More than other large financial institutions, Goldman relies on trading to generate a profit. This quarter, FICC revenue made up about 21% of net revenue compared to 24.5% of net revenue in the December quarter.

Goldman’s results were particularly poor when compared to Bank of America(NYSE:BAC),JPMorgan(NYSE:JPM), and Citigroup(NYSE:C), all of which reported improvements in trading revenue. Bank of America reported a 17% increase in FICC revenue this quarter over the same period last year. Likewise, JPMorgan reported revenue of $4.2 billion in its Fixed Income Markets breakout, a 17% improvement compared to the same period a year ago.Citi stole the show with a 19% increase in fixed-income revenue compared to the prior-year period.

stock picks: CytomX Therapeutics, Inc.(CTMX)

Advisors’ Opinion:

  • [By Lisa Levin]

    CytomX Therapeutics Inc (NASDAQ: CTMX) shares were also up, gaining 24 percent to $18.89. Bristol-Myers Squibb Co (NYSE: BMY) and CytomX Therapeutics disclosed that they have extended worldwide partnership to discover Probody therapeutics for the treatment of cancer and other diseases.

stock picks: Freeport-McMoran, Inc.(FCX)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Freeport-McMoRan (FCX) soared to the top of the S&P 500 today as metal & mining stocks rallied sharply after President Donald J. Trump signed executive orders meant to increase spending on infrastructure.

    Agence France-Presse/Getty Images

    Freeport-McMoRangained 8.4% to $17.04 at 4:12 p.m. today, while the S&P 500 rose 0.7% to 2,280.07.

    In a note released yesterday, Jefferies analyst Christopher LaFemina and team noted that investor interest in Freeport-McMoRan and other miners has been rising:

    We met with 52 investors in the US over the past two weeks and have done calls with 117 investors globally over the past three weeks. This all follows a week of 30 investor meetings in London in December. The mix has been slightly more hedge funds than long only funds, but long only interest in mining has greatly increased. We expect the sector to outperform as fundamentals improve and long only rotation into mining continues. Buy Glencore, Freeport-McMoRan, Fortescue Metals, Rio Tinto (RIO), and BHP Billiton (BHP).

    Freeport-McMoRan’s market capitalization rose to $24.6 billion today from $21.4 billion yesterday. It reported net income of $12.2 billion on sales of $16.3 billion in 2015.

    Freeport-McMoRan is scheduled to report earnings tomorrow.

  • [By Ben Levisohn]

    Freeport-McMoRan (FCX) tumbled to the bottom of the S&P 500 today as the dollar rose and copper prices fell.

    Agence France-Presse/Getty Images

    Freeport-McMoRandropped 4.9% to $13.31 today, while the S&P 500 fell 0.6% to 2,381.92. The ICE U.S. Dollar Index rose 0.4% today, and
    Front Month Comex Copper for March delivery declined 1.7% to $2.6795 today.

    Axiom Capital’s Gordon Johnson warns that iron ore prices might be ready to drop:

    Beware: An Imminent End to an Epic Restock Suggests Iron Ore Prices May Snap Back Toward Fundamentals. Our work suggests ~70% of global iron ore demand can be met at a cash cost of <$23/t; add in $8/t for interest, CAPEX, & other, & we get to a breakeven of $31/t. In addition, w/ inventory restocking & current prices making further investment attractive, despite current excesses, we believe iron ore prices should be ~$40/t (i.e., below marginal costs); in this fashion, w/ Chinese real estate investment on the decline, we view iron ore spot prices >$62/t as a stretch. So what has been propping prices? In our view, one word restocking; first by the mills, undergoing the biggest restocking effort of Chinese steel in >6-yrs., & then by the traders, which have built their iron ore port stocks to a record, w/ days of inventory at a 2.5-yr. high (Ex. 18-19). Yet, w/ data pointing to peak steel inventory, implying risk to n-term ore demand, & the govt probing speculative trading, we see the current restocking cycle as very much so in the later innings

    Freeport-McMoRan’s market capitalization fell to $19.2 billion today from $20.2 billion yesterday. It reported a net loss of $4 billion on sales of $14.8 billion in 2016.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Freeport-McMoran Inc. (NYSE: FCX) which rose about 4% to $14.73. The stocks 52-week range is $9.24 to $17.06. Volume was nearly 21 million compared to its average volume of 18.5 million.

  • [By Reuben Gregg Brewer]

    Freeport-McMoRan Inc. (NYSE:FCX) and Barrick Gold (NYSE:ABX) rank among the largest gold and copper miners in the world. After years of retrenching, both are in better operational and financial shape than they were when commodity prices started to tumble in 2011. But now that metals prices are finally rising, there are new troubles to face. Barrick’s headwinds, however, don’t look nearly as formidable as what Freeport-McMoRan is facing.

  • [By Craig Jones]

    On CNBC's Fast Money Halftime Report, Jon Najarian spoke about unusually high options activity in Freeport-McMoRan Inc (NYSE: FCX). He said that traders were buying the January 13, 14-strike calls on Tuesday. He added that these calls expire prior to the earnings release and he is wondering if someone is betting that the company is going to pre-announce earnings results. Around 9,000 contracts were traded in the first half of the session and Jon Najarian decided to follow the trade. He is planning to hold the long position in Freeport-McMoRan for a week.

  • [By Jon C. Ogg]

    The metals and mining sector has seen many winners, particularly in steel and copper. Freeport-McMoRan Inc. (NYSE: FCX) is big in copper and shares were last seen down 0.3% at $13.90 late on Monday, which might have been up more had it been less diversified. Shares of Freeport-McMoRanare up 26% in the past fivetrading days. The stock has a market cap of $18 billion.

stock picks: iShares MSCI Emerging Markets (EEM)

Advisors’ Opinion:

  • [By Dan Caplinger]

    2017 has been a tumultuous year, with plenty going on in the political and financial realms. Yet the stock market has done quite well, and index funds that track popular stock benchmarks have given their investors solid returns. In particular, among the most popular exchange-traded funds, iShares MSCI Emerging Markets (NYSEMKT:EEM), PowerShares QQQ (NASDAQ:QQQ), and iShares Core MSCI EAFE (NYSEMKT:IEFA) have delivered some of the best returns.

  • [By Craig Jones]

    On CNBC's Trading Nation, Todd Gordon recommended a bearish options strategy in iShares MSCI Emerging Markets Indx (ETF) (NYSE: EEM). He said that the ETF is under pressure because of weak commodity prices and strong U.S. dollar. He explained that falling bond prices have caused a rally in the U.S. dollar.

  • [By Craig Jones]

    Speaking on Bloomberg Markets, Dan Deming of KKM Financial suggested a bullish options strategy in iShares MSCI Emerging Markets Indx (ETF) (NYSE: EEM).

  • [By WWW.GURUFOCUS.COM]

    For the details of RABOBANK NEDERLAND ‘s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=RABOBANK+NEDERLAND+

    These are the top 5 holdings of RABOBANK NEDERLAND Bank of America Corporation (BAC) – 250,000 shares, 100% of the total portfolio. New PositionBlackBerry Ltd (BBRY) – 0 shares, 0% of the total portfolio. Shares reduced by 10000%iShares MSCI Emerging Index Fund (EEM) – 0 shares, 0% of the total portfolio. Shares reduced by 10000%iShares MSCI Brazil Capped Index Fund (EWZ) – 0 shares, 0% of the total portfolio. Shares reduced by 10000%VanEck Vectors Gold Miners (GDX) – 0 shares, 0% of the total portfolio. Shares reduced by 10000%

  • [By Shah Gilani]

    7) iShares MSCI Emerging Markets ETF (NYSEArca:EEM) traded $603 billion in shares

    6) Amazon.com Inc. (NasdaqGS:AMZN) traded $710 billion in shares

stock picks: Citigroup Inc.(C)

Advisors’ Opinion:

  • [By John Maxfield]

    It was about a century ago that Citigroup (NYSE:C) decided to chart a separate course from the rest of the bank industry. It continued to build its domestic operations, but shifted much of its focus to creating a vast network of banking offices around the world.

  • [By Matthew Cochrane]

    With this mindset, it is no wonder that PayPal finished 2016 on a wave of deal-making momentum. In the past 12 months, PayPal completed agreements with a number of financial and tech companies including Alibaba Group Holding Ltd (NYSE: BABA), Citigroup Inc (NYSE: C), Facebook Inc (NASDAQ: FB), Mastercard Inc (NYSE: MA), Visa Inc (NYSE: V), and Vodafone Group Plc (NASDAQ: VOD).

  • [By John Ballard]

    Partnerships play a crucial role in extending PayPal’s reach to new customers and driving higher engagement. The deal with Visa(NYSE:V) opened the door for partnerships with Mastercard(NYSE:MA), Citigroup(NYSE:C), and Fidelity National Information Services (NYSE:FIS). As a result, more deals will come that will increase PayPal’s relevancy and ubiquity in the mobile payment landscape.

  • [By Craig Jones]

    Dan Nathan spoke on CNBC's Options Action about a bearish options strategy in Citigroup Inc (NYSE: C).

    The banking sector traded sharply higher on expectations of deregulation and higher interest rates, but it showed some signs of weakness last week. Nathan thinks the current administration won't be able to change meaningfully the Dodd-Frank Act over the next few months and he sees that as the key catalyst for a possible pull back in the banking sector.

  • [By Casey Wilson]

    America’s Oldest Companies No. 3: Citigroup Inc. (NYSE: C)

    Citigroup was originally founded in 1812 with $2 million in capital as the “City Bank of New York.” Almost 50 years later, in 1865, it joined the U.S. national banking system and quickly rose to the title of “largest bank in the United States” at the time.

stock picks: Vanda Pharmaceuticals Inc.(VNDA)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another biotechnology player that looks poised to trigger a big breakout trade is Vanda Pharmaceuticals (VNDA), which is focused on the development and commercialization of clinical-stage drug candidates for central nervous system disorders. This stock has been on fire so far in 2013, with shares up a whopping 258%.

    If you take a look at the chart for Vanda Pharmaceuticals, you’ll notice that this stock has recently broke out above some near-term overhead resistance levels at $12.34 to $12.66 a share with solid upside volume. So far, this breakout has held and now shares of VNDA are quickly moving within range of triggering an even bigger breakout trade.

    Traders should now look for long-biased trades in VNDA if it manages to break out above its 52-week high at $13.30 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action 908,467 shares. If that breakout hits soon, then VNDA will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $17 a share.

    Traders can look to buy VNDA off any weakness to anticipate that breakout and simply use a stop that sits right below some near-term support at $12 a share. One could also buy VNDA off strength once it takes out $13.30 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.